Mental Health Trends Among US Youths: Rising Prevalence of Depression and Anxiety

By Staff Writer

October 7, 2024

Introduction

Mental health disorders, particularly depression and anxiety, significantly impact US children and adolescents. With an annual cost of $247 billion, these conditions affect millions and pose a substantial burden on society. Recent data highlights an increase in clinically diagnosed depression and anxiety among youths aged 5 to 22 years from 2017 to 2021. These trends are drawn from a large integrated healthcare system in Southern California. A recent analysis focuses on the incidence and prevalence of these disorders, considering factors such as age, gender, race, ethnicity, and weight status.

Rising Incidence and Prevalence

The period from 2017 to 2021 saw a marked increase in clinically diagnosed depression and anxiety among youths. Depression incidence rose by 55.6%, while prevalence increased by 60.0%. Anxiety without depression also showed significant growth, with a 31.1% rise in incidence and a 35.2% increase in prevalence. These trends were more pronounced during the COVID-19 pandemic, reflecting heightened mental health challenges during this period. Adolescents aged 14 to 17 and young adults aged 18 to 22 experienced the highest rates of depression. Anxiety without depression was notably higher among underweight individuals.

Figure 1. Prevalence of Clinically Diagnosed Depression per 100 Participants From 2017 to 2021

Demographic Disparities

The study reveals significant disparities in mental health diagnoses across various demographic groups. Female youths, those of American Indian, Alaska Native, or non-Hispanic White descent, and individuals from higher-income households exhibited higher rates of depression. Anxiety without depression was more prevalent among underweight individuals. These findings align with previous research indicating higher depression and anxiety rates among girls, older children, and those of White ethnicity. Interestingly, the study found higher depression and anxiety rates among youths from affluent families, contrasting with earlier survey data.

Impact of Weight Status

Weight status emerged as a critical factor influencing anxiety without depression. Underweight individuals exhibited the highest incidence and prevalence rates. Previous studies suggest that weight-related teasing may contribute to social isolation and mental health issues among underweight youths. Findings emphasise the need for early interventions to address anxiety in this group, potentially preventing the onset of depression. Obesity, a known risk factor for depression, further complicates the mental health landscape for affected youths.

 

COVID-19 Pandemic Influence

The COVID-19 pandemic significantly disrupted healthcare systems and exacerbated mental health challenges for adolescents. The data indicate that the pandemic contributed to the rising trends in depression and anxiety diagnoses. Despite healthcare access challenges, the rates of newly diagnosed clinical depression did not decline during 2020. Instead, the pandemic intensified existing trends, with 2021 recording the highest incidence of depression and anxiety without depression. This highlights the need for robust mental health services to support youths during and beyond the pandemic.

Conclusion

This recent study highlights the increasing incidence and prevalence of clinically diagnosed depression and anxiety without depression among US youths. These trends, observed across all demographic groups, call for enhanced mental health services. Addressing disparities in mental health diagnoses and providing early interventions for at-risk groups, such as underweight individuals, are crucial steps toward improving the well-being of our young population. As we navigate the post-pandemic landscape, strengthening mental health support systems remains imperative.

Reference url

Recent Posts

lenacapavir HIV prevention
      

Lenacapavir HIV Prevention: Approval and Access Strategy Updates

🌍 *Could a twice-yearly shot revolutionize HIV prevention?*
Gilead Sciences has submitted key applications to the EMA for lenacapavir, a groundbreaking HIV-1 capsid inhibitor designed for use as pre-exposure prophylaxis (PrEP). With promising trial results indicating a significant reduction in HIV infections, this innovation could enhance adherence to prevention strategies globally. Discover more about this game-changing development!

#SyenzaNews #globalhealth #healthcareInnovation

Africa health partnership
      

Strengthening Africa Health Partnership

🌍 Can collaboration redefine Africa’s health landscape?

A newly signed Memorandum of Understanding between Africa CDC and Global Health EDCTP3 promises to enhance health research, clinical trials, and pandemic preparedness on the continent. With a focus on training, local manufacturing, and equitable partnerships, this initiative aims to address pressing global health challenges while improving health outcomes across Africa.

Look into the details of this transformative partnership and its implications for the future of healthcare in the region!

#SyenzaNews #globalhealth #HealthcareInnovation

breast cancer Africa
    

Urgent Call for Enhanced Breast Cancer Africa Control Measures

🚨 Are we doing enough to tackle the imminent breast cancer crisis in Africa?

A recent WHO report reveals alarming trends, predicting that 135,000 women could succumb to breast cancer by 2040 unless urgent actions are taken. The report highlights critical gaps in healthcare infrastructure and capacity, emphasizing the need for investment in screening programs and professional training to improve outcomes across the continent.

Review the full article to explore the necessary steps towards reinforcing breast cancer control measures in Africa.

#SyenzaNews #globalhealth #oncology #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.